A major breakthrough in reducing the severity of multiple sclerosis (MS) has apparently been made by University of Bristol scientists.
In the study carried out on mice and human brain tissue, the researchers found that neuropeptide 'galanin' was resistant to the MS-like disease, experimental autoimmune encephalomyelitis (EAE).
"The results were really remarkable, rarely do you see such a dramatic effect as this," the Daily Express quoted Professor David Wynick, who works on the function of galanin in the relief of neuropathic pain, as saying.
"Mice with high levels of galanin just didn't develop any signs of disease," he added.
Although the researchers say that results are extremely "promising", they insist that lot more needs to be done to figure out how this works before a drug can be developed.